Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
6.13 -0.35 / -5.40%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.10 -0.03 / -0.49%
 
Volume: 4.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues17.4M31.5M53.8M33.9M
 
 
 
 
 
Cost of Goods Sold8.7M11.7M14.8M11.1M
 
 
 
 
 
Depreciation And Amortization2.0M10.2M18.7M18.4M
 
 
 
 
 
 
Operating ExpensesGross Income6.7M9.6M20.3M4.4M
 
 
 
 
 
General Expenses14.1M15.3M22.9M22.0M
 
 
 
 
 
Research And Development345.6K290.0K2.3M994.0K
 
 
 
 
 
Total Operating Expenses24.8M37.2M56.4M51.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.4M-5.7M-2.5M-17.6M
 
 
 
 
 
Extraordinary Charge----0.00-1.3M
 
 
Interest Expense On Debt2.3M5.3M10.0M9.4M
 
 
 
 
 
Other Expenses-368.1K6.0K-82.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.0M-11.0M-12.6M-28.2M
 
 
 
 
 
Income Taxes-3.7M-655.0K-4.8M-4.6M
 
 
 
 
 
Net Income-6.2M-11.7M-7.8M-23.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.8M38.1M38.3M38.5M
 
 
 
 
 
Shares To Calculate EPS Diluted37.8M38.1M38.3M38.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.31-$0.20-$0.62
 
 
 
 
 
EPS Diluted-$0.16-$0.31-$0.20-$0.62
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account